Articles tagged "N/A"

2022 American Transplant Congress
Differences in Medication Adherence Between Preemptive and Post-Dialysis Young Kidney Transplant Recipients
Y. Vaisbourd¹, E. Samson², A. De Simone², M. Dahhou², B. Foster³
¹Pediatrics, McGill University, Montréal, QC, Canada, ²McGill University, Montréal, QC, Canada, ³Montreal Children's Hospital, Montreal, QC, Canada
*Purpose: The mechanisms underlying the superior graft survival associated with pre-emptive kidney transplantation, compared with transplantation following a period of dialysis, are unknown. Selection for…
2021 American Transplant Congress
Living Donor Liver Transplant for Unresectable Colorectal Metastasis: A Case Series
B. Emmanuel, H. Al-Harakeh, A. Humar, C. Hughes, A. Tevar, M. Molinari, A. Ganoza
Starzl Transplant Institute, UPMC, Pittsburgh, PA
*Purpose: Colorectal Cancer (CRC) represents the third most common malignancy worldwide. In the US, CRC lifetime risk is approximately 1 in 23 (4.4%) for men…
2021 American Transplant Congress
Compatible Paired Donation in Paired Kidney Exchange: A Look at the Road Not Taken
G. Vranic, A. Gilbert, B. Thomas, S. Ghasemian, M. Cooper, J. Verbesey
MedStar Georgetown Transplant Institute, Washington, DC
*Purpose: Paired kidney exchange (PKE) offers incompatible donor-recipient pairs increased access to transplant. Compatible pairs are increasingly joining the PKE in an effort to find…
2021 American Transplant Congress
Covid-19 Caseload and Management Practices Vary by Program-Level Factors: A Multinational Survey Study
S. Sandal¹, B. Boyarsky², P. Chiang², A. Massie², D. Segev², M. Cantarovich¹
¹McGill University, Montreal, QC, Canada, ²Johns Hopkins University, Baltimore, MD
*Purpose: During the pandemic, the COVID-19 patient caseload (CPC) is thought to be highly variable and likely dependant on the cumulative COVID-19 incidence (CCI) of…
2021 American Transplant Congress
Sars-cov-2 Stat Testing for Organ Donation; One Laboratory’s Experience
S. Dionne, B. O'Neale
VRL-Eurofins, Centennial, CO
*Purpose: The COVID-19 pandemic took the U.S. by storm. The Transplant Community had to navigate through unprecedented scenarios in order to continue the life-saving mission…
2021 American Transplant Congress
A Randomized, Multicenter, Blinded Study Assessing the Effects of Gaseous Nitric Oxide in an Ex Vivo System of Human Lungs
M. G. Hartwig¹, J. A. Klapper¹, N. Poola², A. Banga³, P. G. Sanchez⁴, J. S. Murala³, J. L. Potenziano²
¹Duke University Medical Center, Durham, NC, ²Mallinckrodt Pharmaceuticals, Bedminster, NJ, ³University of Texas Southwestern Medical Center, Dallas, TX, ⁴University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: The effects of nitric oxide (NO) on donor lungs during ex vivo lung perfusion (EVLP) have not been studied. We assessed whether the novel…
2021 American Transplant Congress
Transplant Trainee Education and Recruitment Experiences
D. E. Cassidy¹, A. E. Gomez-Rexode¹, J. R. Santos-Parker¹, M. S. Anderson², L. M. McElroy³, M. E. Byrnes², S. A. Waits², V. S. Valbuena²
¹University of Michigan Medical School, Ann Arbor, MI, ²Department of Surgery, University of Michigan Health System, Ann Arbor, MI, ³Department of Surgery, Duke University Medical Center, Durham, NC
*Purpose: The demand for training in abdominal transplantation has continued to decrease. General surgery residents have less exposure to transplant surgery, creating a need for…
2021 American Transplant Congress
Quantiferon-tb Gold Plus in Liver Transplant Candidates: Single-center Experience
J. Simkins¹, M. A. Mendoza¹, A. Chandorkar¹, Y. Natori¹, S. Anjan¹, L. R. Arosemena¹, R. Vianna²
¹Medicine, University of Miami, Miami, FL, ²Surgery, University of Miami, Miami, FL
*Purpose: QuantiFERON-TB (QFT) is the preferred diagnostic test for latent tuberculosis infection (LTBI). The QFT-Gold Plus (QFT-Plus) data in OLT candidates is limited.*Methods: Our hospital…
2021 American Transplant Congress
Monoclonal Antibodies for Covid-19 in Patients with Solid Organ Transplant Recipients
L. Hasan¹, H. Hardgrave², T. Osborn³, R. Dare¹, L. Burdine⁴, E. Giorgakis⁴, J. Rico¹
¹Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, ²University of Arkansas for Medical Sciences, Little Rock, AR, ³Surgery, University of Arkansas for Medical Sciences, Little Rock, AR, ⁴Transplant surgery, University of Arkansas for Medical Sciences, Little Rock, AR
*Purpose: The FDA has issued Emergency Use Authorization (EUA) for monoclonal antibodies for the treatment of mild to moderate COVID-19 in patients at risk for…
2021 American Transplant Congress
Utility of Screening-Bead Assay in Post-Transplant Testing of Donor-Specific Antibodies (DSA) and Antibody-mediated Rejection (ABMR) in Renal Allografts
A. Agrawal¹, E. Dijke², A. Murray³, P. Campbell³
¹Transplant Nephrology, Mayo Clinic, Rochester, MN, ²Lab. Medicine and Pathology, University of Alberta Hospital, Edmonton, AB, Canada, ³Division of Nephrology, Dept. of Medicine, University of Alberta Hospital, Edmonton, AB, Canada
*Purpose: ABMR is a major cause of poor long-term graft survival. Though post-transplant monitoring of HLA DSAs can aid in risk stratification and optimizing immunosuppression,…